NCT04750304

Brief Summary

Osteoarthritis is the most common joint disease affecting the joint in a comprehensive and progressive manner. It leads to increasing disability. The recommendations of recent years favor the non-pharmacological treatment of osteoarthritis including regular physical activity, therapeutic education and weight loss Osteoarthritis population has a low level of physical activity due to a lack of information, motivation and false beliefs related to physical activity and kinesiophobia (fear of movement) A preliminary qualitative study (ARTHe1) evaluating the barriers and levers of the use of an e-health therapeutic education application in patients with osteoarthritis was carried out in order to guide the development of the ARTHe application. The objective of this study is to have the application tested on a panel of patients in order to assess the benefits of using the application in terms of adherence to the practice of physical activity but also in clinical terms on function and pain, and the satisfaction of the patient

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
32

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Jan 2022

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 10, 2021

Completed
1 day until next milestone

First Posted

Study publicly available on registry

February 11, 2021

Completed
12 months until next milestone

Study Start

First participant enrolled

January 31, 2022

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 7, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 7, 2022

Completed
Last Updated

July 11, 2022

Status Verified

February 1, 2022

Enrollment Period

5 months

First QC Date

February 10, 2021

Last Update Submit

July 8, 2022

Conditions

Keywords

OsteoarthritisGonarthrosissmarthpone applicatione-Health

Outcome Measures

Primary Outcomes (3)

  • Excercie adherence

    Measured with Exercice Adherence Rating Scale (EARS) on 5 point Likert scale, 0= totally agree, 5 = totally disagree

    3 weeks

  • Excercie adherence

    Measured with Exercice Adherence Rating Scale (EARS) on 5 point Likert scale, 0= totally agree, 5 = totally disagree

    6 weeks

  • Excercie adherence

    Measured with Exercice Adherence Rating Scale (EARS) on 5 point Likert scale, 0= totally agree, 5 = totally disagree

    3 months

Secondary Outcomes (15)

  • Pain with analogic visual scale

    3 weeks, 6 weeks, 3 months

  • Functional evaluation

    3 weeks, 6 weeks, 3 months

  • Satisfaction questionnaire

    3 months

  • Frequency of opening the application per week

    From day 1 to 3 months

  • Frequency of opening the application with on exercice session per week

    From day 1 to 3 months

  • +10 more secondary outcomes

Interventions

Patient will use ARTHe Application for 3 months

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patient with knee arthritis and using a smartphone

You may qualify if:

  • Patients older than 18 years
  • Patients with least one knee impairment
  • Patients with a smartphone or tablet with at least Android 5 or iOS 11.
  • Volunteer patients willing to participate in the study.

You may not qualify if:

  • Patients with no diagnostic criteria for ACR.
  • Patients with comprehension disorders making it impossible to interview and complete questionnaires or use the application.
  • Refusal to participate or being already included in a research protocol that could influence the current protocol.
  • Patients under guardianship, curatorship or deprived of liberty.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Clermont-Ferrand University Hospital

Clermont-Ferrand, AURA, 63000, France

Location

MeSH Terms

Conditions

OsteoarthritisOsteoarthritis, Knee

Condition Hierarchy (Ancestors)

ArthritisJoint DiseasesMusculoskeletal DiseasesRheumatic Diseases

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 10, 2021

First Posted

February 11, 2021

Study Start

January 31, 2022

Primary Completion

July 7, 2022

Study Completion

July 7, 2022

Last Updated

July 11, 2022

Record last verified: 2022-02

Locations